7459
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

MediPal Holdings Corporation is a pharmaceutical and healthcare distribution group operating through a network of subsidiaries and affiliates. The company manages three primary business segments: the wholesale of medical pharmaceuticals, medical devices, and clinical laboratory reagents; the distribution of cosmetics, daily necessities, and over-the-counter medicines; and the supply of veterinary pharmaceuticals, feed additives, and food processing raw materials. Key subsidiaries include Mediseo, Evals, Ator, and Tochi for medical distribution; Paltac for consumer health products; and MP Agro, Signi, and MP Gokyoku Food & Chemical for veterinary and food-related supplies. The group also provides specialized services such as logistics, insurance agency, and database management for medical materials. Operations focus on the Japanese market, serving hospitals, pharmacies, veterinary clinics, and food manufacturers.

Summarised from the annual report, fiscal year ended Mar 2026

Industry Medical Distribution Homepage medipal.co.jp
Sector Healthcare IR page medipal.co.jp
Tags
pharmaceutical distribution, medical devices, veterinary pharmaceuticals, cosmetics wholesale, food additives, healthcare logistics, clinical laboratory reagents, over-the-counter medicines, Mediseo, Evals, Ator, Tochi, SPLine, MM Corporation, Astec, Medie, Premedica, Flora Discovery, M.I.C., MediPal Insurance Service, Presque Cube, Medisheet, Paltac, MP Agro, Signi Holdings, Signi, MP Gokyoku Food & Chemical
Press page medipal.co.jp/news

Metrics

Valuation  
Market cap ¥ 637.126B
Market cap (USD) $ 3.982B
P/E 13.89
PEG 4.47
P/BV 1.03
P/S 0.16
P/OCF 11.77
P/FCF 17.24
Dividend yield 2.2%
Turnover / mcap —
Returns  
ROE 5.5%
ROI 5.3%
ROIC 4.3%
Profit margin 1.1%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 3.1%
Quality  
Profitable Yes
Margin expanding No
Buying back stock Yes
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 37
Quality score 16.7%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 3.817T 3.671T 3.559T 3.36T 3.291T 3.211T 3.253T 3.182T 3.146T 3.064T 3.028T 2.873T 2.948T 2.811T
Net profit 42.534B 40.279B 41.474B 38.806B 29.423B 23.926B 37.968B 34.359B 34.78B 29.011B 30.771B 23.687B 25.485B 18.655B
Free cash flow 36.865B 48.128B 42.448B 2.642B 42.339B 18.78B 29.565B 45.225B 33.058B 12.117B -16.41B — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Share price 2.937K 2.334K 2.315K 1.809K 2.015K 2.121K 2.026K 2.633K 2.175K 1.743K 1.78K 1.564K 1.579K 1.332K
Price performance 12m 0.26 0.01 0.28 -0.1 -0.05 0.05 -0.23 0.21 0.25 -0.02 0.14 -0.01 0.19 —

Filed figures

Figure Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Trade receivables (JPY) 689B 698B 687B 689B 702B 712B 729B 758B 764B 808B
↳ YoY growth -1.6% +1.2% -1.5% +0.3% +1.9% +1.5% +2.4% +3.9% +0.7% +5.8%
↳ 5y CAGR +0.1% +0.7% +0.9% +2.0% +2.1% +2.8%
Other receivables (JPY) 64B 65.2B 64.9B 65.1B 65.1B 63.7B 67.9B 66.5B 66.8B 69.8B
Borrowings, current (JPY) 11.2B 16.1B 8.45B 3.56B 350M — — — — —
Borrowings, non-current (JPY) 15.5B 39.9B 34.4B 30.7B 30.2B — — — — —
Bonds payable (JPY) — 30.7B 30.5B 30.4B 30.2B — — — — —
Cash and deposits (JPY) 165B 204B 213B 208B 223B 243B 195B 230B 261B 289B
Intangible assets (JPY) 12.9B 14.9B 14.1B 11B 10.2B 9.97B 34.2B 39B 39.9B 37.5B
Net debt (borrowings + leases - cash) (JPY) -139B -148B -170B -173B -192B — — — — —
Cash flow detail
Operating cash flow (JPY) 48B 63.6B 63.7B 56.9B 34.4B 61.2B 16.1B 61.8B 60.6B 46.6B
Purchases of property, plant and equipment (JPY) -32.3B -25.6B -14.6B -24.3B -12.8B -16B -10.5B -15.6B -8.86B -6.62B
Purchases of intangible assets (JPY) -3.51B -4.9B -3.91B -3.05B -2.83B -2.92B -3.02B -3.84B -3.57B -3.07B
Change in receivables (cash effect) (JPY) 12.9B -5.1B 10.9B -2.7B -12.7B -10.3B -5.36B -23.1B -5.36B -42.7B
Change in inventories (cash effect) (JPY) -4.39B 1.59B 14M -5.25B -4.28B -3.74B -2.27B -779M -6.12B -11.7B
Change in payables (cash effect) (JPY) -4.81B 3.32B 2.54B 14B 16.4B 7.98B -23.3B 25.3B 8.1B 51.3B
Dividends paid (cash effect) (JPY) -6.79B -7.22B -8.05B -8.65B -8.82B -8.82B -9.66B -11.2B -12.5B -13.2B
Share buybacks (cash effect) (JPY) -1M -2.94B -6.06B -28.3B -2M -1M -1M -10.1B -5.07B -8.09B
Interest paid (cash effect) (JPY) -303M -236M -180M -137M -50M -16M -34M -5M -10M -13M
Income taxes paid (cash effect) (JPY) -22.4B -13.2B -23.3B -29.9B -15.1B -9.62B -24.7B -24.3B -23.7B -25.8B
Operating cash flow before change in receivables (JPY) 35B 68.7B 52.8B 59.6B 47.1B 71.5B 21.5B 84.9B 65.9B 89.3B
Free cash flow (OCF - PPE - intangibles) (JPY) 12.1B 33.1B 45.2B 29.6B 18.8B 42.3B 2.64B 42.4B 48.1B 36.9B
Income detail
Research and development expense (JPY) — — — 118M 106M 108M 103M 991M 1.42B 1.51B
↳ 5y CAGR +64.4% +70.2%
Total comprehensive income (JPY) 40B 64B 35.2B 53.6B 42.6B 25.3B 51.1B 64.7B 46.8B 66.8B
Comprehensive income to owners (JPY) 32.1B 53.7B 25.1B 40.2B 31.5B 16.9B 40.7B 52.5B 36.6B 54.4B
Provision for credit losses (JPY) 390M — 358M — — — — — — —
Credit cost ratio (credit losses / average receivables) (%) 0.1% — 0.0% — — — — — — —
Reported Jun 27, 2017 Jun 26, 2018 Jun 26, 2019 Jun 25, 2020 Jun 25, 2021 Jun 24, 2022 Jun 27, 2023 Jun 25, 2024 Jun 25, 2025 Jun 23, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

定款の一部変更に関するお知らせ Bull 0 Bear 0 Routine

Prompts

MediPal Holdings Corporation (ticker 7459), listed in Japan.

Company History

Date Change Detail
Jul 15, 2026 Acquired Acquired Paltac Corporation (EDINET code E02691). Its filings from before the deal are on its own company page, not shown here.

ETFs Holding MediPal Holdings Corporation

ETF Weight in ETF Shares Market value As of
AVDS 0.16% 28,400 $ 585.043K Nov 16, 2026
AVDV 0.05% 446,100 $ 9.19M Nov 16, 2026
AVSD 0.05% 9,400 $ 193.641K Nov 16, 2026
AVIV 0.04% 44,100 $ 908.465K Nov 16, 2026
DISV 0.04% 100,800 $ 2.016M Nov 12, 2026
DFSI 0.04% 21,400 $ 428K Nov 12, 2026
DXIV 0.04% 4,300 $ 86K Nov 12, 2026
DFIC 0.03% 197,450 $ 3.949M Nov 12, 2026
DFIV 0.02% 231,500 $ 4.63M Nov 12, 2026
AVDE 0.02% 228,300 $ 4.703M Nov 16, 2026
DFIS 0.02% 56,300 $ 1.126M Nov 12, 2026
DFAX 0.02% 98,500 $ 1.97M Nov 12, 2026
DFAI 0.01% 133,000 $ 2.66M Nov 12, 2026